{
  "actions": [
    {
      "acted_at": "2018-04-12", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-04-12", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2665-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "D000607", 
      "district": null, 
      "name": "Donnelly, Joe", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-04-12", 
      "state": "IN", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-04-12", 
  "number": "2665", 
  "official_title": "A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s2680-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": null, 
  "sponsor": {
    "bioguide_id": "Y000064", 
    "district": null, 
    "name": "Young, Todd C.", 
    "state": "IN", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-04-12", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Food and Drug Administration (FDA)", 
    "Government information and archives", 
    "Health", 
    "Health information and medical records", 
    "Medical ethics", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:42:37Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s2665.xml"
}